rising bioscience inc.png

RISING BIOSCIENCES, INC.

Microscope
 

Rising Biosciences (OTC: RBII) operates four distinct business units. The first business unit is a physicians practice management company focused on the proper use of alternative medicines for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.  The fourth unit, Oxi-Thyme™ was developed to help fight the spread of Covid-19 and other harmful viruses and bacteria.  By utilizing a proprietary formulated EPA registered disinfectant with a touch-free delivery system, Oxi-Thyme™ has been able to help businesses across America safe and effectively fight the spread of deadly viruses.

 

ABOUT RISING BIOSCIENCES 

PROJECTS

From Theory to Reality

 
 
oxithyme logo for website.jpg
pao for rising website.jpg
CONTACT US

Thank you for your interest in our research. Get in touch with any questions or comments regarding our work and upcoming projects. We’d love to hear from you.

To receive updates on Rising Biosciences, click the subscribe button below and join our mailing list:

For Investor Inquiries:

  • Facebook Social Icon
 

Follow

  • Facebook Social Icon

© 2019 RISING BIOSCIENCES, INC.